Authors:
GARBARG M
LANNFELT L
BLOMBERG M
WAHLUND LO
FREEDMAN SB
SCHWARTZ C
Citation: M. Garbarg et al., BIOCHEMICAL MARKERS OF HISTAMINERGIC NEURONS IN CEREBROSPINAL-FLUID OF ALZHEIMER PATIENTS AND IN AN ANIMAL-MODEL OF ALZHEIMERS-DISEASE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 911-911
Authors:
KRAUSE M
LIGNEAU X
STARK H
GARBARG M
SCHWARTZ JC
SCHUNACK W
Citation: M. Krause et al., 4-ALKYNYLPHENYL IMIDAZOLYLPROPYL ETHERS AS SELECTIVE HISTAMINE H-3-RECEPTOR ANTAGONISTS WITH HIGH ORAL CENTRAL-NERVOUS-SYSTEM ACTIVITY, Journal of medicinal chemistry, 41(21), 1998, pp. 4171-4176
Authors:
DIMITRIADOU V
ROULEAU A
TUONG MDT
NEWLANDS GJF
MILLER HRP
LUFFAU G
SCHWARTZ JC
GARBARG M
Citation: V. Dimitriadou et al., FUNCTIONAL-RELATIONSHIPS BETWEEN SENSORY NERVE-FIBERS AND MAST-CELLS OF DURA-MATER IN NORMAL AND INFLAMMATORY CONDITIONS, Neuroscience, 77(3), 1997, pp. 829-839
Authors:
ROULEAU A
DIMITRIADOU V
TUONG MDT
NEWLANDS GFJ
MILLER HRP
SCHWARTZ JC
GARBARG M
Citation: A. Rouleau et al., MAST-CELL SPECIFIC PROTEASES IN RAT-BRAIN - CHANGES IN RATS WITH EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, Journal of neural transmission, 104(4-5), 1997, pp. 399-417
Authors:
ROULEAU A
GARBARG M
LIGNEAU X
MANTION C
LAVIE P
ADVENIER C
LECOMTE JM
KRAUSE M
STARK H
SCHUNACK W
SCHWARTZ JC
Citation: A. Rouleau et al., BIOAVAILABILITY, ANTINOCICEPTIVE AND ANTIINFLAMMATORY PROPERTIES OF BP-2-94, A HISTAMINE H-3 RECEPTOR AGONIST PRODRUG, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1085-1094
Authors:
KRAUSE M
ROULEAU A
STARK H
LUGER P
GARBARG M
SCHWARTZ JC
SCHUNACK W
Citation: M. Krause et al., NEW POTENT AZOMETHINE PRODRUGS OF THE HISTAMINE H-3 RECEPTOR AGONIST (R)-ALPHA-METHYLHISTAMINE CONTAINING A HETEROARYLPHENYL PARTIAL STRUCTURE, Archiv der pharmazie, 329(4), 1996, pp. 209-215
Authors:
DIMITRIADOU V
ROULEAU A
TUONG MDT
LIGNEAU X
NEWLANDS GFJ
MILLER HRP
SCHWARTZ JC
GARBARG M
Citation: V. Dimitriadou et al., RAT CEREBRAL MAST-CELLS UNDERGO PHENOTYPIC CHANGES DURING DEVELOPMENT, Developmental brain research, 97(1), 1996, pp. 29-41
Authors:
BUVRY A
GARBARG M
DIMITRIADOU V
ROULEAU A
NEWLANDS GFJ
TAVAKOLI R
POATY V
LOCKHART A
SCHWARTZ JC
FROSSARD N
Citation: A. Buvry et al., PHENOTYPIC AND QUANTITATIVE CHANGES IN MAST-CELLS AFTER SYNGENEIC UNILATERAL LUNG TRANSPLANTATION IN THE RAT, Clinical science, 91(3), 1996, pp. 319-327
Authors:
SOLDANI G
GARBARG M
INTORRE L
BERTINI S
ROULEAU A
SCHWARTZ JC
Citation: G. Soldani et al., MODULATION OF PENTAGASTRIN-INDUCED HISTAMINE-RELEASE BY HISTAMINE H-3RECEPTORS IN THE DOG, Scandinavian journal of gastroenterology, 31(7), 1996, pp. 631-638
Authors:
KRAUSE M
ROULEAU A
STARK H
GARBARG M
SCHWARTZ JC
SCHUNACK W
Citation: M. Krause et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL AZOMETHINE PRODRUGS OF THE HISTAMINE H-3 RECEPTOR AGONIST (R)-ALPHA-METHYLHISTAMINE - FROM ALKYLARYL TO SUBSTITUTED DIARYL DERIVATIVES, Die Pharmazie, 51(10), 1996, pp. 720-726
Authors:
STARK H
PURAND K
HULS A
LIGNEAU X
GARBARG M
SCHWARTZ JC
SCHUNACK W
Citation: H. Stark et al., [I-125] IODOPROXYFAN AND RELATED-COMPOUNDS - A REVERSIBLE RADIOLIGANDAND NOVEL CLASSES OF ANTAGONISTS WITH HIGH-AFFINITY AND SELECTIVITY FOR THE HISTAMINE HS RECEPTOR, Journal of medicinal chemistry, 39(6), 1996, pp. 1220-1226
Authors:
STARK H
PURAND K
LIGNEAU X
ROULEAU A
ARRANG JM
GARBARG M
SCHWARTZ JC
SCHUNACK W
Citation: H. Stark et al., NOVEL CARBAMATES AS POTENT HISTAMINE H-3 RECEPTOR ANTAGONISTS WITH HIGH IN-VITRO AND ORAL IN-VIVO ACTIVITY, Journal of medicinal chemistry, 39(5), 1996, pp. 1157-1163
Authors:
GANELLIN CR
FKYERAT A
BANGANDERSEN B
ATHMANI S
TERTIUK W
GARBARG M
LIGNEAU X
SCHWARTZ JC
Citation: Cr. Ganellin et al., A NOVEL SERIES OF (PHENOXYALKYL)IMIDAZOLES AS POTENT H-3 RECEPTOR HISTAMINE-ANTAGONISTS, Journal of medicinal chemistry, 39(19), 1996, pp. 3806-3813
Citation: M. Imamura et al., HISTAMINE H-3 RECEPTOR-MEDIATED INHIBITION OF CALCITONIN-GENE-RELATEDPEPTIDE RELEASE FROM CARDIAC C-FIBERS - A REGULATORY NEGATIVE-FEEDBACK LOOP, Circulation research, 78(5), 1996, pp. 863-869
Authors:
STARK H
LIPP R
ARRANG JM
GARBARG M
LIGNEAU X
SCHWARTZ JC
SCHUNACK W
Citation: H. Stark et al., NEW POTENT HISTAMINE H-3 RECEPTOR ANTAGONISTS OF THE AMIDE TYPE, European journal of pharmaceutical sciences, 3(2), 1995, pp. 95-104
Authors:
SOLDANI G
GARBARG M
INTORRE L
BERTINI S
ROULEAU A
SCHWARTZ JC
Citation: G. Soldani et al., MODULATION OF PENTAGASTRIN-INDUCED HISTAMINE-RELEASE BY HISTAMINE H-3RECEPTORS IN THE ANESTHETIZED DOG, The FASEB journal, 9(4), 1995, pp. 953-953
Authors:
LIPP R
STARK H
ARRANG JM
GARBARG JM
GARBARG M
SCHWARTZ JC
SCHUNACK W
Citation: R. Lipp et al., SYNTHESIS AND HISTAMINE H-3 RECEPTOR AGONIST ACTIVITY OF MONO-SUBSTITUTED AND DIALKYL-SUBSTITUTED HISTAMINE DERIVATIVES, European journal of medicinal chemistry, 30(3), 1995, pp. 219-225
Citation: C. Leschke et al., SYNTHESIS AND HISTAMINE H-1 RECEPTOR AGONIST ACTIVITY OF A SERIES OF 2-PHENYLHISTAMINES, 2-HETEROARYLHISTAMINES, AND ANALOGS, Journal of medicinal chemistry, 38(8), 1995, pp. 1287-1294
Authors:
KRAUSE M
ROULEAU A
STARK H
LUGER P
LIPP R
GARBARG M
SCHWARTZ JC
SCHUNACK W
Citation: M. Krause et al., SYNTHESIS, X-RAY CRYSTALLOGRAPHY, AND PHARMACOKINETICS OF NOVEL AZOMETHINE PRODRUGS OF (R)-ALPHA-METHYLHISTAMINE - HIGHLY POTENT AND SELECTIVE HISTAMINE H-3 RECEPTOR AGONISTS, Journal of medicinal chemistry, 38(20), 1995, pp. 4070-4079
Authors:
GANELLIN CR
HOSSEINI SK
KHALAF YS
TERTIUK W
ARRANG JM
GARBARG M
LIGNEAU X
SCHWARTZ JC
Citation: Cr. Ganellin et al., DESIGN OF POTENT NON-THIOUREA H-3 RECEPTOR HISTAMINE-ANTAGONISTS, Journal of medicinal chemistry, 38(17), 1995, pp. 3342-3350
Citation: A. Delaunois et al., MODULATION OF ACETYLCHOLINE, CAPSAICIN AND SUBSTANCE-P EFFECTS BY HISTAMINE H-3 RECEPTORS IN ISOLATED-PERFUSED RABBIT LUNGS, European journal of pharmacology, 277(2-3), 1995, pp. 243-250
Citation: Nce. Smith et al., HISTAMINE H-3 RECEPTORS DOWN-REGULATE THE RELEASE OF CALCITONIN-GENE-RELATED PEPTIDE FROM CARDIAC C-FIBERS, Circulation, 92(8), 1995, pp. 2714-2714
Authors:
GOTHERT M
GARBARG M
HEY JA
SCHLICKER E
SCHWARTZ JC
LEVI R
Citation: M. Gothert et al., NEW ASPECTS OF THE ROLE OF HISTAMINE IN CARDIOVASCULAR FUNCTION - IDENTIFICATION, CHARACTERIZATION, AND POTENTIAL PATHOPHYSIOLOGICAL IMPORTANCE OF H-3 RECEPTORS, Canadian journal of physiology and pharmacology, 73(5), 1995, pp. 558-564
Authors:
STARK H
LIPP R
ARRANG JM
GARBARG M
SCHWARTZ JC
SCHUNACK W
Citation: H. Stark et al., ACYLATED AND ALKYLATED HISTAMINE DERIVATIVES AS NEW HISTAMINE H-3 RECEPTOR ANTAGONISTS, European journal of medicinal chemistry, 29(9), 1994, pp. 695-700
Authors:
DIMITRIADOU V
ROULEAU A
TUONG MDT
NEWLANDS GJF
MILLER HRP
LUFFAU G
SCHWARTZ JC
GARBARG M
Citation: V. Dimitriadou et al., FUNCTIONAL-RELATIONSHIP BETWEEN MAST-CELLS AND C-SENSITIVE NERVE-FIBERS EVIDENCED BY HISTAMINE H-3 RECEPTOR MODULATION IN RAT LUNG AND SPLEEN, Clinical science, 87(2), 1994, pp. 151-163